BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Feb 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-02-01

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-01	Common Stock	M	84	$14.39	Acquired	14327	Direct
2011-02-01	Common Stock	M	1250	$17.33	Acquired	15577	Direct
2011-02-01	Common Stock	S	1334	$26.00	Disposed	14243	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-01	Stock Option (right to buy)	$14.39	M	84	Disposed	2019-05-11	Common Stock (84)	Direct
2011-02-01	Stock Option (right to buy)	$17.33	M	1250	Disposed	2017-06-06	Common Stock (1250)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 105-1 Trading plan executed on August 20, 2010.

F2: Original option grant vests 6/48th on November 1, 2009 and 1/48th each on the 12th of each month thereafter.

F3: Original option grant vests 6/48th on December 7, 2007 and 1/48th each on the 7th of each month thereafter.